Jayasree Iyer: Cancer medicine shortages within LMICs
Jayasree Iyer, CEO of Access to Medicine Foundation, recently shared a post by Access to Medicine Foundation on LinkedIn, adding:
“Cancer medicine shortages within LMICs is an underexamined issue that requires a global dialogue and concrete actions to secure a steady supply of essential medicines. Read more in Danielle Barnum’s viewpoint below.”
Quoting Access to Medicine Foundation’s post:
“‘Shortages and stockouts in high-income countries have hit the headlines, but less attention has been paid to how these issues have long affected cancer patients in LMICs and the impact of these shortages.’
This World Cancer Day, in a new viewpoint, the Foundation’s Researcher, Danielle Barnum, brings our attention to shortages and stockouts of #CancerMeds, and the steps manufacturers can take to ensure resilient and sustainable supply chains in low- and middle-income countries.
Sources: Jayasree Iyer/LinkedIn and Access to Medicine Foundation/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023